Stocks
GlaxoSmithKline (GSK) P/FCF US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 27.5 | 38.1 | 12.0 | 19.3 | 8.53 | 16.3 | |||
| Changes by years, y/y, % | +100% | +38% | -68% | +61% | -56% | -5.4% | |||
GlaxoSmithKline. P/FCF
GlaxoSmithKline. P/FCF, changes, %
GlaxoSmithKline (GSK) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | 20.4 | 16.7 | 14.6 | 7.90 | 17.8 | 16.3 | ||
| Changes by years, y/y, % | +18% | -50% | +3% | -54% | -13% | |||
| Changes by quarters, q/q, % | +20% | -18% | -13% | -46% | +125% | |||
